Breakthrough Bacteremia Due to Extended-Spectrum-β-Lactamase-Producing Klebsiella pneumoniae during Combination Therapy with Colistin and Tigecycline

被引：10
|
作者：
Cho, Sun Young [1 ]
Kang, Cheol-In [1 ]
Chung, Doo Ryeon [1 ]
Peck, Kyong Ran [1 ]
Song, Jae-Hoon [1 ]
Jang, Jun Ho [2 ]
机构：
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Infect Dis, Seoul, South Korea
[2] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol, Seoul, South Korea
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2012年 / 56卷 / 09期
关键词：
NDM-1-PRODUCING ENTEROBACTERIACEAE; SYNERGY;
D O I：
10.1128/AAC.01009-12
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页码：4994 / 4995
页数：2
相关论文
共 50 条
  • [1] Reply to "Breakthrough Bacteremia Due to Extended-Spectrum-β-Lactamase-Producing Klebsiella pneumoniae during Combination Therapy with Colistin and Tigecycline"
    Albur, Mahableshwar
    Noel, Alan
    Bowker, Karen
    MacGowan, Alasdair
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (09) : 4996 - 4996
  • [2] Carbapenem Therapy for Bacteremia Due to Extended-Spectrum-β-Lactamase-Producing Escherichia coli or Klebsiella pneumoniae: Implications of Ertapenem Susceptibility
    Lee, Nan-Yao
    Lee, Ching-Chi
    Huang, Wei-Han
    Tsui, Ko-Chung
    Hsueh, Po-Ren
    Ko, Wen-Chien
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (06) : 2888 - 2893
  • [3] Carbapenem therapy for bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae
    Lee, Nan-Yao
    Huang, Wei-Han
    Tsui, Ko-Chung
    Hsueh, Po-Ren
    Ko, Wen-Chien
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2011, 70 (01) : 150 - 153
  • [4] Comparative Antibiofilm Efficacy of Meropenem Alone and in Combination with Colistin in an In Vitro Pharmacodynamic Model by Extended-Spectrum-β-Lactamase-Producing Klebsiella pneumoniae
    Ribera, Alba
    Benavent, Eva
    El-Haj, Cristina
    Gomez-Junyent, Joan
    Tubau, Fe
    Rigo-Bonnin, Raul
    Ariza, Javier
    Murillo, Oscar
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (11)
  • [5] Bacteremia Due to Extended-Spectrum-β-Lactamase-Producing Enterobacter cloacae: Role of Carbapenem Therapy
    Lee, Ching-Chi
    Lee, Nan-Yao
    Yan, Jing-Jou
    Lee, Hsin-Chun
    Chen, Po-Lin
    Chang, Chia-Ming
    Wu, Chi-Jung
    Ko, Nai-Ying
    Wang, Li-Rong
    Chi, Chih-Hsien
    Ko, Wen-Chien
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (09) : 3551 - 3556
  • [6] Ertapenem Resistance among Extended-Spectrum-β-Lactamase-Producing Klebsiella pneumoniae Isolates
    Leavitt, Azita
    Chmelnitsky, Inna
    Colodner, Raul
    Ofek, Itzhak
    Carmeli, Yehuda
    Navon-Venezia, Shiri
    JOURNAL OF CLINICAL MICROBIOLOGY, 2009, 47 (04) : 969 - 974
  • [7] Microbiologic and Clinical Implications of Bacteremia Due to Extended-Spectrum-β-Lactamase-Producing Klebsiella pneumoniae with or without Plasmid-Mediated AmpC β-Lactamase DHA-1
    Lee, Chen-Hsiang
    Su, Lin-Hui
    Li, Chia-Chin
    Chien, Chun-Chih
    Tang, Ya-Fen
    Liu, Jien-Wei
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (12) : 5395 - 5398
  • [8] Carbapenem therapy for bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae: Implications of Ertapenem susceptibility
    Hsueh, P. -R.
    Ko, W. -C.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2012, 16 : E440 - E440
  • [9] Comparison of synergism between colistin, fosfomycin and tigecycline against extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolates or with carbapenem resistance
    Ku, Yee-Huang
    Chen, Chi-Chung
    Lee, Mei-Feng
    Chuang, Yin-Ching
    Tang, Hung-Jen
    Yu, Wen-Liang
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2017, 50 (06) : 931 - 939
  • [10] The changing epidemiology of extended spectrum β-lactamase-producing Klebsiella pneumoniae
    Elhani, Dalele
    Bakir, Leila
    Aouni, Mahjoub
    ANNALES DE BIOLOGIE CLINIQUE, 2011, 69 (05) : 523 - 529
12345